Avid Bioservices Inc (CDMO)

[Thurly]

(earlier response to a PM)

I think it looks bad.

They report great 1st line data and 3 months later, BAM! and they say it's a difference between their reads and the independent investigator reads.

They report great 2nd line data and now, BAM! and they say it's the fault of a 3rd party.

This is after stating in conference calls that they expected the government contract to be renewed and BAM! it wasn't.

They are serial share/price killers.

I'm willing to withhold judgement. But I am not at all optimistic. I would expect, at the least, that the trial endpoints were all invalidated. MOS may be in question.

I doubt they will be able to recoup their losses through insurance.

They have that 30 million dollar loan now. How are they going to pay that off?

Dilution will be catastrophic.

They're screwed financially. They are blood in the water to Wall Street sharks.

I think their only hope is to sell the company, cheap.

I may change my mind after I hear what they have to say, but I can't yet imagine how the situation could be any better than this.

Who is going to trust the PII pancreatic data now?

And if the ISTs don't report some good data...?!

I had a really bad feeling after the last conference call. I covered my cost basis but I should have been smarter and taken some profit.

Biotech, you never know. And, honestly, there was smoke. You have to manage your risk.